Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis
The viridans group streptococci comprise multiple species and have gained more recognition in recent years as common etiologic agents of bacterial endophthalmitis. The purpose of this study was to identify the species of human endophthalmitis isolates of viridans streptococci and to characterize the...
Gespeichert in:
Veröffentlicht in: | PloS one 2018-12, Vol.13 (12), p.e0209849 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 12 |
container_start_page | e0209849 |
container_title | PloS one |
container_volume | 13 |
creator | Marquart, Mary E Benton, Angela H Galloway, Regina C Stempak, Lisa M |
description | The viridans group streptococci comprise multiple species and have gained more recognition in recent years as common etiologic agents of bacterial endophthalmitis. The purpose of this study was to identify the species of human endophthalmitis isolates of viridans streptococci and to characterize their potential virulence attributes. The species of 22 endophthalmitis strains of viridans streptococci were identified by Matrix Assisted Laser Desorption Ionization Time-of-Flight. Susceptibilities to 3 antibiotics commonly used for bacterial endophthalmitis were determined. The extracellular milieu of each strain was tested for cytotoxicity of retinal pigmented epithelial cells, hemolysis of sheep erythrocytes, and protease activity using gelatin zymography. Identified species were Streptococcus mitis/oralis, S. salivarius, S. vestibularis, S. parasanguinis, S. mutans, S. constellatus, and S. gordonii. One strain of S. pseudoporcinus was also identified. All strains were sensitive to vancomycin, 77% were resistant to amikacin, and 27% had intermediate resistance to ceftazidime. Extracellular milieu from all strains except one (S. pseudoporcinus) were largely devoid of toxicity to retinal pigmented epithelial cells and sheep erythrocytes. Twelve strains, 10 of which were S. mitis/oralis, produced protease activity. Interestingly, not all of the S. mitis/oralis strains were proteolytic. These findings highlight the diversity of virulence factor production in ocular strains of the viridans streptococci not only at the group level but also at the species level. |
doi_str_mv | 10.1371/journal.pone.0209849 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2159700805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A566646316</galeid><doaj_id>oai_doaj_org_article_7dc2ea83179f4ae9952400e7d0bfae4d</doaj_id><sourcerecordid>A566646316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-c58ce6f4f213aacc74875b1fdae00ab98f00fa5fe6bc6e1020caec2588d326093</originalsourceid><addsrcrecordid>eNqNkluL2zAQhU1p6W7T_oPSGgqFQpPKli3bL4Ww9BJYWOjtVYzHo0TBsVxJDpt_X2XjXWJooehB0uibI3F0ouhlwhYJL5IPWzPYDtpFbzpasJRVZVY9ii6TiqdzkTL--Gx9ET1zbstYzkshnkYXnOWF4BW_jIZl53WtjdcYu8Eh9cdtq_3hfYwHb7y51Xi3g66Je2s8gaMY0Ot9KMdGxXttdQOdi9fWDH3svA0iBg2ijhEGp7t1TF1j-o3fQLvTXrvn0RMFraMX4zyLfn7-9OPq6_z65svqank9R1Glfo55iSRUptKEAyAWWVnkdaIaIMagrkrFmIJckahRUBJMQCBM87JseCpYxWfR65Nu3xonR8ecTJO8Khgrgx-zaHUiGgNb2Vu9A3uQBrS8Kxi7lmCDOS3JosGUoORJUakMqKryNGOMiobVCihrgtbH8bah3lGD1HkL7UR0etLpjVybvRSccVakQeDNKGDN74Gc_8eTR2oN4VW6UyaI4U47lMtcCJEJnohALf5ChdHQTmPIjNKhPml4N2kIjKdbvw4_6OTq-7f_Z29-Tdm3Z-yGoPUbZ9rBa9O5KZidQLTGOUvqwbmEyWPk792Qx8jLMfKh7dW56w9N9xnnfwDFKgBh</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2159700805</pqid></control><display><type>article</type><title>Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Marquart, Mary E ; Benton, Angela H ; Galloway, Regina C ; Stempak, Lisa M</creator><creatorcontrib>Marquart, Mary E ; Benton, Angela H ; Galloway, Regina C ; Stempak, Lisa M</creatorcontrib><description>The viridans group streptococci comprise multiple species and have gained more recognition in recent years as common etiologic agents of bacterial endophthalmitis. The purpose of this study was to identify the species of human endophthalmitis isolates of viridans streptococci and to characterize their potential virulence attributes. The species of 22 endophthalmitis strains of viridans streptococci were identified by Matrix Assisted Laser Desorption Ionization Time-of-Flight. Susceptibilities to 3 antibiotics commonly used for bacterial endophthalmitis were determined. The extracellular milieu of each strain was tested for cytotoxicity of retinal pigmented epithelial cells, hemolysis of sheep erythrocytes, and protease activity using gelatin zymography. Identified species were Streptococcus mitis/oralis, S. salivarius, S. vestibularis, S. parasanguinis, S. mutans, S. constellatus, and S. gordonii. One strain of S. pseudoporcinus was also identified. All strains were sensitive to vancomycin, 77% were resistant to amikacin, and 27% had intermediate resistance to ceftazidime. Extracellular milieu from all strains except one (S. pseudoporcinus) were largely devoid of toxicity to retinal pigmented epithelial cells and sheep erythrocytes. Twelve strains, 10 of which were S. mitis/oralis, produced protease activity. Interestingly, not all of the S. mitis/oralis strains were proteolytic. These findings highlight the diversity of virulence factor production in ocular strains of the viridans streptococci not only at the group level but also at the species level.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0209849</identifier><identifier>PMID: 30576393</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Amikacin ; Animals ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Bacteria ; Biofilms ; Biology and Life Sciences ; Ceftazidime ; Ceftazidime - pharmacology ; Ceftazidime - therapeutic use ; Cytotoxicity ; Diabetic retinopathy ; Endophthalmitis ; Endophthalmitis - drug therapy ; Endophthalmitis - microbiology ; Epidemiology ; Epithelial cells ; Erythrocytes ; Erythrocytes - drug effects ; Etiology ; Gelatin ; Gene mutation ; Genetic aspects ; Humans ; Immunology ; Ionization ; Medicine and Health Sciences ; Microbial Sensitivity Tests ; Ovis aries ; Pathogenesis ; Protease ; Proteinase ; Proteolysis ; Retina ; Risk factors ; Sheep ; Species ; Strains (organisms) ; Streptococcal infections ; Streptococcus ; Streptococcus infections ; Toxicity testing ; Vancomycin ; Vancomycin - pharmacology ; Vancomycin - therapeutic use ; Viridans Streptococci - drug effects ; Virulence ; Virulence Factors</subject><ispartof>PloS one, 2018-12, Vol.13 (12), p.e0209849</ispartof><rights>COPYRIGHT 2018 Public Library of Science</rights><rights>2018 Marquart et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2018 Marquart et al 2018 Marquart et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-c58ce6f4f213aacc74875b1fdae00ab98f00fa5fe6bc6e1020caec2588d326093</citedby><cites>FETCH-LOGICAL-c692t-c58ce6f4f213aacc74875b1fdae00ab98f00fa5fe6bc6e1020caec2588d326093</cites><orcidid>0000-0002-3557-6048</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303072/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303072/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30576393$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marquart, Mary E</creatorcontrib><creatorcontrib>Benton, Angela H</creatorcontrib><creatorcontrib>Galloway, Regina C</creatorcontrib><creatorcontrib>Stempak, Lisa M</creatorcontrib><title>Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>The viridans group streptococci comprise multiple species and have gained more recognition in recent years as common etiologic agents of bacterial endophthalmitis. The purpose of this study was to identify the species of human endophthalmitis isolates of viridans streptococci and to characterize their potential virulence attributes. The species of 22 endophthalmitis strains of viridans streptococci were identified by Matrix Assisted Laser Desorption Ionization Time-of-Flight. Susceptibilities to 3 antibiotics commonly used for bacterial endophthalmitis were determined. The extracellular milieu of each strain was tested for cytotoxicity of retinal pigmented epithelial cells, hemolysis of sheep erythrocytes, and protease activity using gelatin zymography. Identified species were Streptococcus mitis/oralis, S. salivarius, S. vestibularis, S. parasanguinis, S. mutans, S. constellatus, and S. gordonii. One strain of S. pseudoporcinus was also identified. All strains were sensitive to vancomycin, 77% were resistant to amikacin, and 27% had intermediate resistance to ceftazidime. Extracellular milieu from all strains except one (S. pseudoporcinus) were largely devoid of toxicity to retinal pigmented epithelial cells and sheep erythrocytes. Twelve strains, 10 of which were S. mitis/oralis, produced protease activity. Interestingly, not all of the S. mitis/oralis strains were proteolytic. These findings highlight the diversity of virulence factor production in ocular strains of the viridans streptococci not only at the group level but also at the species level.</description><subject>Amikacin</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Biofilms</subject><subject>Biology and Life Sciences</subject><subject>Ceftazidime</subject><subject>Ceftazidime - pharmacology</subject><subject>Ceftazidime - therapeutic use</subject><subject>Cytotoxicity</subject><subject>Diabetic retinopathy</subject><subject>Endophthalmitis</subject><subject>Endophthalmitis - drug therapy</subject><subject>Endophthalmitis - microbiology</subject><subject>Epidemiology</subject><subject>Epithelial cells</subject><subject>Erythrocytes</subject><subject>Erythrocytes - drug effects</subject><subject>Etiology</subject><subject>Gelatin</subject><subject>Gene mutation</subject><subject>Genetic aspects</subject><subject>Humans</subject><subject>Immunology</subject><subject>Ionization</subject><subject>Medicine and Health Sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Ovis aries</subject><subject>Pathogenesis</subject><subject>Protease</subject><subject>Proteinase</subject><subject>Proteolysis</subject><subject>Retina</subject><subject>Risk factors</subject><subject>Sheep</subject><subject>Species</subject><subject>Strains (organisms)</subject><subject>Streptococcal infections</subject><subject>Streptococcus</subject><subject>Streptococcus infections</subject><subject>Toxicity testing</subject><subject>Vancomycin</subject><subject>Vancomycin - pharmacology</subject><subject>Vancomycin - therapeutic use</subject><subject>Viridans Streptococci - drug effects</subject><subject>Virulence</subject><subject>Virulence Factors</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNkluL2zAQhU1p6W7T_oPSGgqFQpPKli3bL4Ww9BJYWOjtVYzHo0TBsVxJDpt_X2XjXWJooehB0uibI3F0ouhlwhYJL5IPWzPYDtpFbzpasJRVZVY9ii6TiqdzkTL--Gx9ET1zbstYzkshnkYXnOWF4BW_jIZl53WtjdcYu8Eh9cdtq_3hfYwHb7y51Xi3g66Je2s8gaMY0Ot9KMdGxXttdQOdi9fWDH3svA0iBg2ijhEGp7t1TF1j-o3fQLvTXrvn0RMFraMX4zyLfn7-9OPq6_z65svqank9R1Glfo55iSRUptKEAyAWWVnkdaIaIMagrkrFmIJckahRUBJMQCBM87JseCpYxWfR65Nu3xonR8ecTJO8Khgrgx-zaHUiGgNb2Vu9A3uQBrS8Kxi7lmCDOS3JosGUoORJUakMqKryNGOMiobVCihrgtbH8bah3lGD1HkL7UR0etLpjVybvRSccVakQeDNKGDN74Gc_8eTR2oN4VW6UyaI4U47lMtcCJEJnohALf5ChdHQTmPIjNKhPml4N2kIjKdbvw4_6OTq-7f_Z29-Tdm3Z-yGoPUbZ9rBa9O5KZidQLTGOUvqwbmEyWPk792Qx8jLMfKh7dW56w9N9xnnfwDFKgBh</recordid><startdate>20181221</startdate><enddate>20181221</enddate><creator>Marquart, Mary E</creator><creator>Benton, Angela H</creator><creator>Galloway, Regina C</creator><creator>Stempak, Lisa M</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-3557-6048</orcidid></search><sort><creationdate>20181221</creationdate><title>Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis</title><author>Marquart, Mary E ; Benton, Angela H ; Galloway, Regina C ; Stempak, Lisa M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-c58ce6f4f213aacc74875b1fdae00ab98f00fa5fe6bc6e1020caec2588d326093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Amikacin</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Biofilms</topic><topic>Biology and Life Sciences</topic><topic>Ceftazidime</topic><topic>Ceftazidime - pharmacology</topic><topic>Ceftazidime - therapeutic use</topic><topic>Cytotoxicity</topic><topic>Diabetic retinopathy</topic><topic>Endophthalmitis</topic><topic>Endophthalmitis - drug therapy</topic><topic>Endophthalmitis - microbiology</topic><topic>Epidemiology</topic><topic>Epithelial cells</topic><topic>Erythrocytes</topic><topic>Erythrocytes - drug effects</topic><topic>Etiology</topic><topic>Gelatin</topic><topic>Gene mutation</topic><topic>Genetic aspects</topic><topic>Humans</topic><topic>Immunology</topic><topic>Ionization</topic><topic>Medicine and Health Sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Ovis aries</topic><topic>Pathogenesis</topic><topic>Protease</topic><topic>Proteinase</topic><topic>Proteolysis</topic><topic>Retina</topic><topic>Risk factors</topic><topic>Sheep</topic><topic>Species</topic><topic>Strains (organisms)</topic><topic>Streptococcal infections</topic><topic>Streptococcus</topic><topic>Streptococcus infections</topic><topic>Toxicity testing</topic><topic>Vancomycin</topic><topic>Vancomycin - pharmacology</topic><topic>Vancomycin - therapeutic use</topic><topic>Viridans Streptococci - drug effects</topic><topic>Virulence</topic><topic>Virulence Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marquart, Mary E</creatorcontrib><creatorcontrib>Benton, Angela H</creatorcontrib><creatorcontrib>Galloway, Regina C</creatorcontrib><creatorcontrib>Stempak, Lisa M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marquart, Mary E</au><au>Benton, Angela H</au><au>Galloway, Regina C</au><au>Stempak, Lisa M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2018-12-21</date><risdate>2018</risdate><volume>13</volume><issue>12</issue><spage>e0209849</spage><pages>e0209849-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>The viridans group streptococci comprise multiple species and have gained more recognition in recent years as common etiologic agents of bacterial endophthalmitis. The purpose of this study was to identify the species of human endophthalmitis isolates of viridans streptococci and to characterize their potential virulence attributes. The species of 22 endophthalmitis strains of viridans streptococci were identified by Matrix Assisted Laser Desorption Ionization Time-of-Flight. Susceptibilities to 3 antibiotics commonly used for bacterial endophthalmitis were determined. The extracellular milieu of each strain was tested for cytotoxicity of retinal pigmented epithelial cells, hemolysis of sheep erythrocytes, and protease activity using gelatin zymography. Identified species were Streptococcus mitis/oralis, S. salivarius, S. vestibularis, S. parasanguinis, S. mutans, S. constellatus, and S. gordonii. One strain of S. pseudoporcinus was also identified. All strains were sensitive to vancomycin, 77% were resistant to amikacin, and 27% had intermediate resistance to ceftazidime. Extracellular milieu from all strains except one (S. pseudoporcinus) were largely devoid of toxicity to retinal pigmented epithelial cells and sheep erythrocytes. Twelve strains, 10 of which were S. mitis/oralis, produced protease activity. Interestingly, not all of the S. mitis/oralis strains were proteolytic. These findings highlight the diversity of virulence factor production in ocular strains of the viridans streptococci not only at the group level but also at the species level.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>30576393</pmid><doi>10.1371/journal.pone.0209849</doi><tpages>e0209849</tpages><orcidid>https://orcid.org/0000-0002-3557-6048</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2018-12, Vol.13 (12), p.e0209849 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2159700805 |
source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
subjects | Amikacin Animals Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibiotics Bacteria Biofilms Biology and Life Sciences Ceftazidime Ceftazidime - pharmacology Ceftazidime - therapeutic use Cytotoxicity Diabetic retinopathy Endophthalmitis Endophthalmitis - drug therapy Endophthalmitis - microbiology Epidemiology Epithelial cells Erythrocytes Erythrocytes - drug effects Etiology Gelatin Gene mutation Genetic aspects Humans Immunology Ionization Medicine and Health Sciences Microbial Sensitivity Tests Ovis aries Pathogenesis Protease Proteinase Proteolysis Retina Risk factors Sheep Species Strains (organisms) Streptococcal infections Streptococcus Streptococcus infections Toxicity testing Vancomycin Vancomycin - pharmacology Vancomycin - therapeutic use Viridans Streptococci - drug effects Virulence Virulence Factors |
title | Antibiotic susceptibility, cytotoxicity, and protease activity of viridans group streptococci causing endophthalmitis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T09%3A17%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotic%20susceptibility,%20cytotoxicity,%20and%20protease%20activity%20of%20viridans%20group%20streptococci%20causing%20endophthalmitis&rft.jtitle=PloS%20one&rft.au=Marquart,%20Mary%20E&rft.date=2018-12-21&rft.volume=13&rft.issue=12&rft.spage=e0209849&rft.pages=e0209849-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0209849&rft_dat=%3Cgale_plos_%3EA566646316%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2159700805&rft_id=info:pmid/30576393&rft_galeid=A566646316&rft_doaj_id=oai_doaj_org_article_7dc2ea83179f4ae9952400e7d0bfae4d&rfr_iscdi=true |